Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, starboard value
Former Pfizer CEO, finance chief step back from Starboard's activist campaign
The about face comes as the board grapples with the activist's efforts, and just days before Starboard's Jeff Smith was slated to meet with the CEO, sources said.
Former Pfizer CEO, CFO say they will not be involved in Starboard's campaign against drugmaker
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, which reportedly wants the U.S. drug giant to make changes to turn its performance around.
Pfizer’s Former CEO Won’t Be Involved in Starboard Value Effort
Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist campaign against the drug company, according to statement released on their behalf late Wednesday.
4h
Ex Pfizer CEO, CFO not to involve in Starboard's campaign on drugmaker
Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of ...
3d
Starboard reportedly takes $1 billion stake in Pfizer, seeks changes
Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a ...
2d
Starboard Value takes $1 billion stake in Pfizer: Reports
An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...
2d
on MSN
Pfizer Stock Rises After It Gets an Activist. What Starboard’s Track Record With Pharma Tells Us.
Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...
2d
Pfizer goes from hunter to hunted as Starboard circles
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Pfizer
Ian Read
COVID-19
Frank D'Amelio
Albert Bourla
Feedback